Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime
1 other identifier
interventional
320
1 country
1
Brief Summary
The purpose of this study is to investigate the use of 3-5 minutes air therapy for the prevention and treatment of diaper dermatitis in infants 30 weeks and older receiving care in the neonatal intensive care unit (NICU).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2025
CompletedFirst Submitted
Initial submission to the registry
April 21, 2025
CompletedFirst Posted
Study publicly available on registry
May 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 21, 2027
February 17, 2026
February 1, 2026
2.5 years
April 21, 2025
February 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Occurrence of diaper dermatitis
Whether infant is diagnosed with diaper dermatitis while in the NICU
from admission to discharge from NICU, up to 6 months
Study Arms (2)
Air Therapy
EXPERIMENTALPatients with receive 3-5 minutes of air therapy in addition to routine diaper care
Routine Care
NO INTERVENTIONPatients will receive routine diaper care
Interventions
Eligibility Criteria
You may qualify if:
- Receiving care at Good Samaritan Hospital NICU
- At least 30 weeks gestation at birth and corrected or older or corrected gestation
- Birth to 1 year old
- Stable vital signs (temperature, pulse, blood pressure, and oxygen saturation)
You may not qualify if:
- Parent/legal guardian unable or unavailable to consent to involvement in the study
- Congenital malformation impacting diaper area or spine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TriHealth Inc.lead
Study Sites (1)
Good Samaritan Hospital
Cincinnati, Ohio, 45220, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gina Marie Allaire
TriHealth Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2025
First Posted
May 6, 2025
Study Start
January 21, 2025
Primary Completion (Estimated)
July 21, 2027
Study Completion (Estimated)
December 21, 2027
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share